爱普斯坦-巴尔病毒通过上调ANXA3-HIF-1α-VEGF通路导致上皮质恶性瘤的血管异常
Yuanyuan Chen1,2, Muping Di3, Yan Tang1,2
1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 510060, Guangzhou, China.
Oncogene
|May 22, 2024
概括
埃普斯坦-巴尔病毒 (EBV) 感染促进异常瘤血管,恶化缺氧和生长. 阻断ANXA3并与免疫疗法结合,在治疗EBV相关癌症方面显示出有前途.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 血管生物学 血管生物学
背景情况:
- 血管新生是癌症的标志,有助于治疗耐药性.
- 爱斯坦-巴尔病毒 (EBV) 与上皮瘤有关,但其在瘤血管化中的作用尚不清楚.
研究的目的:
- 调查EBV感染对瘤血管异常的影响,并阐明潜在机制.
- 确定EBV相关瘤的潜在治疗点.
主要方法:
- 对临床患者瘤样本和老鼠异种移植模型的分析.
- 研究了ANXA3-HIF-1α-VEGF通路. 这是一个很好的例子.
- 评估了ANXA3基因沉默和抗体中和.
- 用NK细胞和PD1抗体对ANXA3阻断进行评估的联合治疗.
主要成果:
- 受EBV感染的瘤呈现出增加的,不成熟的新血管化,功能异常 ( perfusion 差,通透性高).
- EBV感染加剧了瘤缺氧,通过ANXA3-HIF-1α-VEGF途径加速瘤生长.
- ANXA3阻塞减少了血管异常,增强了免疫细胞透,并减轻了治疗耐药性.
结论:
- EBV感染通过ANXA3-HIF-1α-VEGF通路驱动瘤血管异常.
- 在EBV感染的瘤中,ANXA3是可行的治疗标.
- 与NK细胞和PD1抗体结合ANXA3阻断的联合治疗显示出与EBV相关的上皮性恶性瘤的显著治疗潜力.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


